title: Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.
abstract: Immunotherapy for B-cell chronic lymphocytic leukaemia (B-CLL) and other haematological malignancies may consist of passive antibody, active immunization or adoptive T-cell transfer. This chapter will focus on T-lymphocyte immunotherapy; an approach supported by earlier observations that the beneficial effects of allogeneic stem cell transplantation depend, in part, on the graft-versus-leukaemia effects mediated by these cells. One promising strategy consists of the genetic manipulation of effector T lymphocytes to express tumour-specific T-cell receptors or chimeric antigen receptors directed against surface antigens on the B-CLL cells. This methodology is now being integrated with the concept that tumour recurrence may be due to the persistence of a reservoir of more primitive and chemoresistant tumour cells, dubbed 'cancer stem cells', with self-renewal capacity. Identification and characterization of these cancer stem cells in B-CLL is crucial for the development of new anti-tumour agents, and for the identification of target antigens for cellular immunotherapy. This chapter will describe how immunotherapy may be directed to a more primitive side population of B-CLL cells.
authors.affiliation: Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, 6621 Fannin Street, MC 3-3320, Houston, Texas 77030, USA.
authors.forename: Aaron E
authors.initials: AE
authors.lastname: Foster
authors.forename: Malcolm K
authors.initials: MK
authors.lastname: Brenner
authors.forename: Gianpietro
authors.initials: G
authors.lastname: Dotti
mesh_terms: D018014:Gene Transfer Techniques; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D015448:Leukemia, B-Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000628:therapy; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics; D013234:Stem Cells / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D016693:Receptors, Antigen, T-Cell, alpha-beta
references.citation: Nat Immunol. 2002 Nov;3(11):999-1005
references.pmid: 12407407
references.citation: N Engl J Med. 1995 Oct 19;333(16):1052-7
references.pmid: 7675049
references.citation: Blood. 1995 Aug 1;86(3):1090-7
references.pmid: 7620163
references.citation: Blood. 2007 Oct 15;110(8):2811-8
references.pmid: 17638850
references.citation: Blood. 1992 Jun 1;79(11):2981-9
references.pmid: 1375120
references.citation: N Engl J Med. 1976 May 6;294(19):1026-30
references.pmid: 815819
references.citation: Br J Haematol. 1999 Sep;106(4):995-1004
references.pmid: 10520003
references.citation: Cancer Res. 2006 Nov 15;66(22):10995-1004
references.pmid: 17108138
references.citation: Neoplasia. 2003 Nov-Dec;5(6):481-8
references.pmid: 14965441
references.citation: Science. 2002 Oct 25;298(5594):850-4
references.pmid: 12242449
references.citation: N Engl J Med. 2000 Dec 14;343(24):1750-7
references.pmid: 11114313
references.citation: Blood. 2000 Aug 1;96(3):785-93
references.pmid: 10910888
references.citation: Blood. 1998 Jun 15;91(12):4694-700
references.pmid: 9616167
references.citation: Nat Med. 2003 Mar;9(3):279-86
references.pmid: 12579196
references.citation: Cancer Res. 2008 Jan 1;68(1):190-7
references.pmid: 18172311
references.citation: Bone Marrow Transplant. 1996 Sep;18(3):669-72
references.pmid: 8879640
references.citation: Am J Pathol. 1990 Aug;137(2):225-32
references.pmid: 2201196
references.citation: Nat Med. 1997 Dec;3(12):1337-45
references.pmid: 9396603
references.citation: Stem Cells. 2006 Jan;24(1):3-12
references.pmid: 16449630
references.citation: J Clin Oncol. 1997 Apr;15(4):1567-74
references.pmid: 9193354
references.citation: Leuk Lymphoma. 2006 Oct;47(10):2028-36
references.pmid: 17071473
references.citation: Blood. 2008 May 1;111(9):4817-26
references.pmid: 18299450
references.citation: J Clin Oncol. 2003 Jul 15;21(14):2747-53
references.pmid: 12860954
references.citation: Nat Biotechnol. 2002 Jan;20(1):70-5
references.pmid: 11753365
references.citation: J Clin Invest. 2005 Dec;115(12):3623-33
references.pmid: 16308572
references.citation: Blood. 2001 Feb 15;97(4):835-43
references.pmid: 11159505
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8639-44
references.pmid: 10411928
references.citation: Blood. 2005 Nov 1;106(9):3062-7
references.pmid: 16020516
references.citation: Nat Med. 1997 Jul;3(7):730-7
references.pmid: 9212098
references.citation: Int J Cancer. 2002 Jan 20;97(3):344-8
references.pmid: 11774286
references.citation: Cancer Res. 2005 Jul 15;65(14):6207-19
references.pmid: 16024622
references.citation: J Clin Invest. 2005 Mar;115(3):755-64
references.pmid: 15711642
references.citation: Nature. 2003 May 15;423(6937):255-60
references.pmid: 12714970
references.citation: J Exp Med. 1996 Apr 1;183(4):1797-806
references.pmid: 8666936
references.citation: Blood. 2001 May 1;97(9):2777-83
references.pmid: 11313271
references.citation: Hum Gene Ther. 2001 Apr 10;12(6):659-70
references.pmid: 11426465
references.citation: Leukemia. 2006 Oct;20(10):1819-28
references.pmid: 16932339
references.citation: Blood. 1987 Mar;69(3):929-36
references.pmid: 3814821
references.citation: Blood. 1991 Sep 15;78(6):1545-51
references.pmid: 1884021
references.citation: Blood. 2007 Mar 15;109(6):2331-8
references.pmid: 17082316
references.citation: Cytotherapy. 2003;5(2):131-8
references.pmid: 12745575
references.citation: J Clin Invest. 2005 Jul;115(7):1797-805
references.pmid: 15965501
references.citation: Blood. 2002 May 1;99(9):3179-87
references.pmid: 11964281
references.citation: Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6916-23
references.pmid: 16203783
references.citation: Blood. 2005 Mar 15;105(6):2436-42
references.pmid: 15536147
references.citation: J Clin Oncol. 2005 Sep 10;23(26):6325-32
references.pmid: 16155015
references.citation: J Immunol. 1998 Sep 15;161(6):2791-7
references.pmid: 9743337
references.citation: Blood. 2007 Nov 1;110(9):3352-9
references.pmid: 17684154
references.citation: J Natl Cancer Inst. 1971 Feb;46(2):411-22
references.pmid: 5115909
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
references.pmid: 15381773
references.citation: Mol Ther. 2005 Nov;12(5):933-41
references.pmid: 15979412
references.citation: Hepatology. 2006 Jul;44(1):240-51
references.pmid: 16799977
references.citation: Blood. 2007 Oct 15;110(8):2838-45
references.pmid: 17609424
references.citation: Blood. 2006 Dec 1;108(12):3890-7
references.pmid: 16926291
references.citation: Biochem Biophys Res Commun. 2007 Dec 28;364(4):808-14
references.pmid: 17977513
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
references.pmid: 14711994
references.citation: J Clin Oncol. 1999 Jan;17(1):399-408
references.pmid: 10458259
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Int J Oncol. 2006 Jul;29(1):95-103
references.pmid: 16773189
references.citation: Blood. 2016 Jul 28;128(4):465
references.pmid: 27471229
references.citation: Mol Ther. 2007 Oct;15(10):1744-50
references.pmid: 17637721
references.citation: Leuk Lymphoma. 2005 Jan;46(1):11-9
references.pmid: 15621776
references.citation: Mol Ther. 2007 Apr;15(4):825-33
references.pmid: 17299405
references.citation: J Immunol. 2006 Nov 1;177(9):6548-59
references.pmid: 17056587
references.citation: Blood. 2006 May 1;107(9):3779-86
references.pmid: 16391015
references.citation: Bone Marrow Transplant. 2000 Apr;25(7):717-22
references.pmid: 10745256
references.citation: Lancet. 1978 Aug 26;2(8087):444-6
references.pmid: 79806
references.citation: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):720-4
references.pmid: 8421711
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: Blood. 2003 Feb 15;101(4):1637-44
references.pmid: 12393484
references.citation: Nat Med. 1996 May;2(5):551-5
references.pmid: 8616714
references.citation: Blood. 1980 Feb;55(2):282-93
references.pmid: 6928106
references.citation: Blood. 2001 Aug 15;98(4):1166-73
references.pmid: 11493466
references.citation: Lancet. 1995 Jan 7;345(8941):9-13
references.pmid: 7799740
references.citation: Blood. 2005 Mar 1;105(5):1898-904
references.pmid: 15542583
references.citation: Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6106-15
references.pmid: 17062687
references.citation: J Clin Oncol. 2001 Apr 15;19(8):2165-70
references.pmid: 11304768
references.citation: Br J Cancer. 2006 Nov 6;95(9):1202-11
references.pmid: 17024127
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16158-63
references.pmid: 17911267
references.citation: J Exp Med. 1993 Apr 1;177(4):925-35
references.pmid: 7681471
references.citation: EMBO J. 2003 Oct 15;22(20):5323-35
references.pmid: 14532106
references.citation: Hematology Am Soc Hematol Educ Program. 2006;:273-8, 512
references.pmid: 17124072
references.citation: Int Rev Immunol. 1993;10(2-3):279-90
references.pmid: 8360589
references.citation: J Mol Med (Berl). 1999 Feb;77(2):282-93
references.pmid: 10023781
references.citation: Blood. 2000 Nov 1;96(9):2917-24
references.pmid: 11049967
references.citation: Acta Haematol. 2003;110(2-3):154-9
references.pmid: 14583676
references.citation: Nat Rev Immunol. 2002 Jul;2(7):512-9
references.pmid: 12094225
references.citation: Immunol Today. 1999 Oct;20(10):438-41
references.pmid: 10500289
references.citation: Int J Cancer. 2001 Oct 15;94(2):228-36
references.pmid: 11668503